Information  X 
Enter a valid email address

EKF Diagnostics nets £5.6m from sale of stake in AI specialist

By BFN News | 02:20 PM | Thursday 26 November, 2020


Healthcare company EKF Diagnostics has sold more than half of its stake in artificial intelligence-based diagnostics firm Renalytix AI. EKF sold nearly 1.7 million shares at £4.60 each, it announced this morning, raising just over £7.7 million. After dealing expenses, this meant a profit of £5.6 million for EKF, it said. Following the transaction, EKF still holds 1 million shares in Renalytix AI, approximately 1.4% of the company's outstanding shares. At 2:20pm: (LON:EKF) EKF Diagnostics Holdings PLC share price was 0p at 66.75p (LON:RENX) Renalytix Ai PLC share price was 0p at 436p Story provided by StockMarketWire.com

a d v e r t i s e m e n t